Detalles de la búsqueda
1.
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Cancer
; 130(2): 287-299, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801052
2.
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Ann Hematol
; 103(2): 427-436, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012435
3.
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia.
Haematologica
; 108(9): 2396-2409, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021528
4.
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
Hum Genomics
; 16(1): 40, 2022 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36123612
5.
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
Ann Hematol
; 102(6): 1375-1382, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079069
6.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636033
7.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31877211
8.
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study.
Haematologica
; 107(10): 2356-2364, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385922
9.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Ann Hematol
; 100(8): 2005-2014, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388860
10.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Ann Hematol
; 99(7): 1525-1530, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474619
11.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819917
12.
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
Hematol Oncol
; 37(3): 296-302, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30892724
13.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Ann Hematol
; 98(10): 2329-2338, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392461
14.
Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.
Cancer
; 124(10): 2228-2237, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29499087
15.
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study.
Haematologica
; 108(12): 3454-3459, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439348
16.
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment.
Ann Hematol
; 97(5): 745-754, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29468276
17.
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.
Ann Hematol
; 97(9): 1577-1580, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675611
18.
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
Ann Hematol
; 97(1): 95-100, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971265
19.
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Mycoses
; 61(1): 53-60, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28872724
20.
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.
J Cell Biochem
; 118(11): 3968-3975, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28401599